Russo, C.
Caponnetto, P.
Cibella, F.
Maglia, M.
Alamo, A.
Campagna, D.
Frittitta, L.
Di Mauro, M.
Leotta, C.
Mondati, E.
Krysiński, A.
Franek, E.
Polosa, R. http://orcid.org/0000-0002-8450-5721
Funding for this research was provided by:
This investigator initiated research is supported by GRAND (Global Research Award for Nicotine Dependence) an independently reviewed competitive grants program funded by Pfizer Inc (US).
Università degli Studi di Catania
Article History
Received: 30 January 2021
Accepted: 22 February 2021
First Online: 18 March 2021
Compliance with ethical standards
:
: RP is full-time employee of the University of Catania, Italy and Medical Director of the Institute for Internal Medicine and Clinical Immunology at the same University. In relation to his work in the area of tobacco control and respiratory diseases, RP has received has received lecture fees and research funding from Pfizer, GlaxoSmithKline, CV Therapeutics, NeuroSearch A/S, Sandoz, MSD, Boehringer Ingelheim, Novartis, Duska Therapeutics, and Forest Laboratories. He has also served as a consultant for Pfizer, Global Health Alliance for treatment of tobacco dependence, CV Therapeutics, Boehringer Ingelheim, Novartis, Duska Therapeutics, ECITA (Electronic Cigarette Industry Trade Association, in the UK), Arbi Group Srl., and Health Diplomats. RP has served on the Medical and Scientific Advisory Board (MSAB) of Cordex Pharma, Inc., CV Therapeutics, Duska Therapeutics Inc, Pfizer, and PharmaCielo. Lecture fees from a number of European EC industry and trade associations (including FIVAPE in France and FIESEL in Italy) were directly donated to vaper advocacy no-profit organizations. RP is also founder of: 1) the Center for Tobacco prevention and treatment (CPCT) at the University of Catania; and 2) the Center of Excellence for the acceleration of Harm Reduction (CoEHAR) at the same University, which has received support from Foundation for a Smoke Free World to conduct 8 independent investigator-initiated research projects on harm reduction. RP is also currently involved in the following pro bono activities: scientific advisor for LIAF, Lega Italiana Anti Fumo (Italian acronym for Italian Anti-Smoking League), the Consumer Advocates for Smoke-free Alternatives (CASAA) and the International Network of Nicotine Consumers Organizations (INNCO); Chair of the European Technical Committee for standardization on “Requirements and test methods for emissions of electronic cigarettes” (CEN/TC 437; WG4). PC is paid by the University of Catania as an external part time researcher and adjunct professor of clinical, addiction and general psychology. He has been affiliated to the CoEHAR since December 2019 in a pro bono role. He is co-author of a protocol paper supported by an Investigator-Initiated Study award program established by Philip Morris International in 2017. All other authors have no relevant conflict of interest to declare in relation to this study.
: This article does not contain any studies with human or animal subjects performed by the any of the authors.
: For this type of study, formal consent is not required.